Clinical Trial Update: Determination of New Biomarkers of Septic Arthritis by Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF)

View source ↗

Summary

This completed study reports on identifying new biomarkers for septic arthritis using SELDI-TOF technology, conducted at University Hospital in Grenoble.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Septic Arthritis

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Acute Arthritis | Status: COMPLETED